↓ Skip to main content

Dove Medical Press

Article Metrics

Reporting of adverse events related to dietary supplements to a public health center by medical staff: a survey of clinics and pharmacies

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
23 Mendeley
Title
Reporting of adverse events related to dietary supplements to a public health center by medical staff: a survey of clinics and pharmacies
Published in
Therapeutics and Clinical Risk Management, September 2016
DOI 10.2147/tcrm.s111749
Pubmed ID
Authors

Hiroshi Yamada, Kazuki Ide, Yohei Kawasaki, Marika Noguchi, Mamoru Kitagawa, Tsuyoshi Chiba, Yoshiyuki Kagawa, Keizo Umegaki

Abstract

Dietary supplements are used by >50% of the adult population in Japan, and adverse events related to these products have been reported with their increased use. Thus, an efficient system to gather and report data on these adverse events is essential. To date, however, reporting has been limited. The aim of this study was to address this deficiency by exploring the routine reporting practices of the medical staff employed at clinics or pharmacies in Japan. We conducted a survey of the procedures used by the medical staff to report adverse events related to dietary supplement intake to public health centers in Japan. The survey was conducted in Japan between November 2015 and January 2016. Based on a sample size calculation, questionnaires were administered to 1,700 potential respondents (850 pharmacists and 850 physicians). The questionnaire inquired about the sociodemographic characteristics and dietary supplement-related adverse event-reporting practices. The response rate was 34.7%, including 286 pharmacists and 304 physicians. Although >30% of the pharmacists and physicians had prior experience dealing with such adverse events, <5% had reported these to a public health center. The survey identified several barriers to reporting, such as "difficulty judging the relationship between an adverse event and the dietary supplement" and "lack of clarity regarding the severity of an adverse event". This is the first study to explore the routine reporting practices of physicians and pharmacists in terms of adverse events related to dietary supplements. Further studies are required to elucidate the severity of these adverse events. Moreover, standard reporting criteria ought to be introduced to improve public health.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 22%
Student > Bachelor 4 17%
Student > Master 4 17%
Other 3 13%
Researcher 3 13%
Other 3 13%
Unknown 1 4%
Readers by discipline Count As %
Nursing and Health Professions 6 26%
Medicine and Dentistry 3 13%
Agricultural and Biological Sciences 2 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 4 17%
Unknown 5 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2016.
All research outputs
#6,635,040
of 12,485,238 outputs
Outputs from Therapeutics and Clinical Risk Management
#377
of 922 outputs
Outputs of similar age
#104,760
of 262,777 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#8
of 49 outputs
Altmetric has tracked 12,485,238 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 922 research outputs from this source. They receive a mean Attention Score of 4.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,777 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.